Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CORTICOSTEROID-INDUCED OSTEOPOROSIS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 198 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pande, I; Francis, RM
      Osteoporosis in men

      BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    2. Woo, T; Adachi, JD
      Role of bisphosphonates and calcitonin in the prevention and treatment of osteoporosis

      BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    3. Ettinger, B; Chidambaran, P; Pressman, A
      Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs

      AMERICAN JOURNAL OF MANAGED CARE
    4. Papaioannou, A; Ferko, NC; Adachi, JD
      All patients with inflammatory bowel disease should have bone density assessment: Pro

      INFLAMMATORY BOWEL DISEASES
    5. Fan, SLS; Cunningham, J
      Bisphosphonates in renal osteodystrophy

      CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
    6. Kumar, R
      Glucocorticoid-induced osteoporosis

      CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
    7. Sylvester, FA
      An update on bone abnormalities associated with gastrointestinal and liverdisease

      ENDOCRINOLOGIST
    8. Clowes, JA; Peel, N; Eastell, R
      Glucocorticoid-induced osteoporosis

      CURRENT OPINION IN RHEUMATOLOGY
    9. Sen, D; Keen, RW
      Osteoporosis in systemic lupus erythematosus: prevention and treatment

      LUPUS
    10. Mikuls, TR; Saag, KG
      Comorbidity in rheumatoid arthritis

      RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
    11. Amin, S; Felson, DT
      Osteoporosis in men

      RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
    12. Woitge, HW; Seibel, MJ
      Biochemical markers to survey bone turnover

      RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
    13. Watts, NB
      Treatment of osteoporosis with bisphosphonates

      RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
    14. Lane, NE
      An update on glucocorticoid-induced osteoporosis

      RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
    15. Carbonare, LD; Arlot, ME; Chavassieux, PM; Roux, JP; Portero, NR; Meunier, PJ
      Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis

      JOURNAL OF BONE AND MINERAL RESEARCH
    16. Boutsen, Y; Jamart, J; Esselinckx, W; Devogelaer, JP
      Primary prevention of gluccocorticoid-induced osteoporosis with intravenous pamidronate and calcium: A prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone

      JOURNAL OF BONE AND MINERAL RESEARCH
    17. Orcel, P
      Chronic respiratory failure and osteoporosis: a difficult problem to unravel

      REVUE DES MALADIES RESPIRATOIRES
    18. Scharla, SH; Buttgereit, F; Dreher, R; Felsenberg, D; Franck, H; Hein, G; Lemmel, EM; Rau, R; Sieper, J; Braun, J
      Preliminary consensus statement on glucorticoid-induced osteoporosis

      ZEITSCHRIFT FUR RHEUMATOLOGIE
    19. Mudano, A; Allison, J; Hill, J; Rothermel, T; Saag, K
      Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort

      JOURNAL OF RHEUMATOLOGY
    20. Cacoub, P; Chemlal, K; Khalifa, P; Wechsler, B; De Gennes, C; Belmatoug, N; Cohen, P; Ziza, JM; Verdoncq, B; Piette, JC
      Deflazacort versus prednisone in patients with giant cell arteritis: Effects on bone mass loss

      JOURNAL OF RHEUMATOLOGY
    21. Smith, MD; Ross, W; Ahern, MJ
      Missing a therapeutic window of opportunity: An audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip and wrist fractures

      JOURNAL OF RHEUMATOLOGY
    22. Koller, H; Mayer, G
      Immunosuppressive therapy and bone metabolism after kidney transplantation

      ACTA MEDICA AUSTRIACA
    23. Compston, J
      Secondary causes of osteoporosis in men

      CALCIFIED TISSUE INTERNATIONAL
    24. Cheung, AM
      Post-liver transplantation osteoporosis

      JOURNAL OF HEPATOLOGY
    25. Umland, EM; Boyce, EG
      Risedronate: A new oral bisphosphonate

      CLINICAL THERAPEUTICS
    26. Braun, J; Sieper, J
      Osteoporosis due to steroid therapy

      ORTHOPADE
    27. Sewell, K; Schein, JR
      Osteoporosis therapies for rheumatoid arthritis patients: Minimizing gastrointestinal side effects

      SEMINARS IN ARTHRITIS AND RHEUMATISM
    28. Arlen, DJ; Lambert, K; Ioannidis, G; Adachi, JD
      Treatment of established bone loss after renal transplantation with etidronate

      TRANSPLANTATION
    29. Tyrovola, JB; Spyropoulos, MN
      Effects of drugs and systemic factors on orthodontic treatment

      QUINTESSENCE INTERNATIONAL
    30. Dinc, M; Tchugunova, Y; Dinc, S; Cinarli, B; Atasever, T; Oz, M
      Decreased osteocalcin levels in patients with chronic obstructive pulmunary disease using long-term inhaled beclomethasone dipropionate

      METABOLISM-CLINICAL AND EXPERIMENTAL
    31. Rosen, CJ; Bilezikian, JP
      Clinical review 123: Hot topic - Anabolic therapy for osteoporosis

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    32. Niedermeier, A; Messer, G
      Glucocorticoid-induced osteoporosis. An often underestimated consequence of long term therapy of autoimmune diseases

      HAUTARZT
    33. Sharpe, M; Noble, S; Spencer, CM
      Alendronate - An update of its use in osteoporosis

      DRUGS
    34. Dunn, CJ; Goa, KL
      Risedronate - A review of its pharmacological properties and clinical use in resorptive bone disease

      DRUGS
    35. Buckley, L; Greenwald, M; Hochberg, M; Lane, N; Lindsey, S; Paget, S; Saag, K; Simon, L
      Recommendations for the prevention and treatment of glucocorticoid-inducedosteoporosis - 2001 update

      ARTHRITIS AND RHEUMATISM
    36. Adachi, JD; Saag, KG; Delmas, PD; Liberman, UA; Emkey, RD; Seeman, E; Lane, NE; Kaufman, JM; Poubelle, PEE; Hawkins, F; Correa-Rotter, R; Menkes, CJ; Rodriguez-Portales, JA; Schnitzer, TJ; Block, JA; Wing, J; McIlwain, HH; Westhovens, R; Brown, J; Melo-Gomes, JA; Gruber, BL; Yanover, MJ; Leite, MOR; Siminoski, KG; Nevitt, MC; Sharp, JT; Malice, MP; Dumortier, T; Czachur, M; Carofano, W; Daifotis, A
      Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids - A randomized, double-blind, placebo-controlled extension trial

      ARTHRITIS AND RHEUMATISM
    37. Naganathan, V; Sambrook, P
      Osteoporosis and fracture disk prevention in long-term glucocorticoid therapy - Reply

      ARCHIVES OF INTERNAL MEDICINE
    38. Yood, RA; Harrold, LR; Fish, L; Cernieux, J; Emani, S; Conboy, E; Gurwitz, JH
      Prevention of glucocorticoid-induced osteoporosis - Experience in a managed care setting

      ARCHIVES OF INTERNAL MEDICINE
    39. Yosipovitch, G; Hoon, TS; Leok, GC
      Suggested rationale for prevention and treatment of glucocorticoid-inducedbone loss in dermatologic patients

      ARCHIVES OF DERMATOLOGY
    40. Reid, IR
      Time to end steroid-induced fractures

      ARCHIVES OF DERMATOLOGY
    41. Wolfhagen, FHJ; van Buuren, HR; Vleggaar, FP; Schalm, SW
      Management of osteoporosis in primary biliary cirrhosis

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    42. Reid, IR
      Glucocorticoid-induced osteoporosis

      BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
    43. Conron, M; Young, C; Beynon, HLC
      Calcium metabolism in sarcoidosis and its clinical implications

      RHEUMATOLOGY
    44. Struijs, A; Smals, A; de Witte, SA; Hackeng, WHL; Mulder, H
      Acute effects of etidronate on glucocorticoid-induced bone degradation

      RHEUMATOLOGY
    45. Cooper, MS; Stewart, PM
      Therapeutic patenting for glucocorticoid-induced osteoporosis

      EXPERT OPINION ON THERAPEUTIC PATENTS
    46. Lespessailles, E; Poupon, S; Adriambelosoa, N; Pothuaud, L; Siroux, V; Bouillon, S; Benhamou, CL
      Glucocrticoid-induced osteoporosis: is the bone density decrease the only explanation?

      JOINT BONE SPINE
    47. Hanley, DA; Ioannidis, G; Adachi, JD
      Etidronate therapy in the treatment and prevention of osteoporosis

      JOURNAL OF CLINICAL DENSITOMETRY
    48. Osiri, M; Saag, KG; Ford, AM; Moreland, LW
      Practice pattern variation among internal medicine specialists in the prevention of glucocorticoid-induced osteoporosis

      JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
    49. Elliott, ME; Farrah, RM; Binkley, NC; Carnes, ML; Gudmundsson, A
      Management of glucocorticoid-induced osteoporosis in male veterans

      ANNALS OF PHARMACOTHERAPY
    50. Colao, A; Loche, S; Cappabianca, P; de Divitiis, E; Lombardi, G
      Pituitary adenomas in children and adolescents. Clinical presentation, diagnosis, and therapeutic strategies

      ENDOCRINOLOGIST
    51. Manelli, F; Giustina, A
      Glucocorticoid-induced osteoporosis

      TRENDS IN ENDOCRINOLOGY AND METABOLISM
    52. Wilcox, A; Bharadwaj, P; Sharma, OP
      Bone sarcoidosis

      CURRENT OPINION IN RHEUMATOLOGY
    53. Tannirandorn, P; Epstein, S
      Drug-induced bone loss

      OSTEOPOROSIS INTERNATIONAL
    54. Lane, NE; Sanchez, S; Genant, HK; Jenkins, DK; Arnaud, CD
      Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis

      OSTEOPOROSIS INTERNATIONAL
    55. Schulte, C; Beelen, DW; Schaefer, UW; Mann, K
      Bone loss in long-term survivors after transplantation of hematopoietic stem cells: A prospective study

      OSTEOPOROSIS INTERNATIONAL
    56. Bijlsma, JWJ; Jacobs, JWG
      Hormonal preservation of bone in rheumatoid arthritis

      RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
    57. Kenny, AM; Prestwood, KM
      Osteoporosis - Pathogenesis, diagnosis, and treatment in older adults

      RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
    58. Cunnane, G; Lane, NE
      Steroid-induced osteoporosis in systemic lupus erythematosus

      RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
    59. Lane, NE; Sanchez, S; Modin, GW; Genant, HK; Pierini, E; Arnaud, CD
      Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: Results of a randomized controlled clinical trial

      JOURNAL OF BONE AND MINERAL RESEARCH
    60. Chavassieux, PM; Arlot, ME; Roux, JP; Portero, N; Daifotis, A; Yates, AJ; Hamdy, NAT; Malice, MP; Freedholm, D; Meunier, PJ
      Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: A histomorphometric analysis of transiliac biopsies

      JOURNAL OF BONE AND MINERAL RESEARCH
    61. Pfeilschifter, J; Diel, IJ
      Osteoporosis due to cancer treatment: Pathogenesis and management

      JOURNAL OF CLINICAL ONCOLOGY
    62. Allolio, B; Dambacher, M; Dreher, R; Felsenberg, D; Franke, J; Kruse, HP; Leidig-Bruckner, G; Ringe, JD; Semler, J; Willvonseder, R; Ziegler, R
      Osteoporosis in males

      MEDIZINISCHE KLINIK
    63. Mazzantini, M; Lane, NE
      Rheumatic diseases, glucocorticoid treatment and bone mass: Recent developments

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    64. Weinstein, RS
      The pathogenesis of glucocorticoid-induced osteoporosis

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    65. Ringe, JD; Faber, H
      Calcium and vitamin D in the prevention and treatment of glucocorticoid-induced osteoporosis

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    66. Roux, C; Dougados, M
      Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    67. Wu, F; Reid, IR
      Calcitonin in the prevention and treatment of glucocorticoid-induced osteoporosis

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    68. Geusens, P
      Hormonal replacement therapy in the prevention and treatment of glucocorticoid-induced osteoporosis

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    69. Lems, WF; Jacobs, JWG; Bijlsma, JWJ
      Fluoride in the prevention and treatment of glucocorticoid-induced osteoporosis

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    70. Brandi, ML
      New perspectives in the prevention and treatment of glucocorticoid-inducedosteoporosis

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    71. Boulos, P; Adachi, JD
      Guidelines for the prevention and therapy of glucocorticoid-induced osteoporosis

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    72. Lambrinoudaki, I; Kung, AWC
      Management of steroid-induced osteoporosis

      CHINESE MEDICAL JOURNAL
    73. Ringe, JD; Coster, A; Meng, T; Schacht, E; Umbach, R
      Therapy of glucocorticoid-induced osteoporosis alfacalcidol/calcium or vitamin D/calcium

      ZEITSCHRIFT FUR RHEUMATOLOGIE
    74. Kaiser, H
      Glucocorticoid therapy in rheumatology - yesterday today tomorrow

      ZEITSCHRIFT FUR RHEUMATOLOGIE
    75. Reid, IR
      Preventing glucocorticoid-induced osteoporosis

      ZEITSCHRIFT FUR RHEUMATOLOGIE
    76. Lambrinoudaki, I; Chan, DTM; Lau, CS; Wong, RWS; Yeung, SSC; Kung, AWC
      Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study

      JOURNAL OF RHEUMATOLOGY
    77. Kirchgatterer, A; Aschl, G; Knoflach, P
      Steroid-induced osteoporosis: Pathogenesis and therapeutic consequences

      ACTA MEDICA AUSTRIACA
    78. Adachi, JD; Ioannidis, G
      Glucocorticoid-induced osteoporosis

      DRUG DEVELOPMENT RESEARCH
    79. Buchman, AL; Moukarzel, A
      Metabolic bone disease associated with total parenteral nutrition

      CLINICAL NUTRITION
    80. Rothberg, AD; Matshidze, PK
      Monitoring and management of bone status in patients on chronic glucocorticoid treatment - The medscheme experience

      SOUTH AFRICAN MEDICAL JOURNAL
    81. Fujita, T; Satomura, A; Hidaka, M; Ohsawa, I; Endo, M; Ohi, H
      Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy

      CALCIFIED TISSUE INTERNATIONAL
    82. Yonemura, K; Kimura, M; Miyaji, T; Hishida, A
      Short-term effect of vitamin K administration on prednisolone-induced lossof bone mineral density in patients with chronic glomerulonephritis

      CALCIFIED TISSUE INTERNATIONAL
    83. Vergne, P; Bertin, P; Bonnet, C; Scotto, C; Treves, R
      Drug-induced rheumatic disorders - Incidence, prevention and management

      DRUG SAFETY
    84. Blair, MM; Carson, DS; Barrington, R
      Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis

      JOURNAL OF FAMILY PRACTICE
    85. Adachi, JD; Olszynski, WP; Hanley, DA; Hodsman, AB; Kendler, DL; Siminoski, KG; Brown, J; Cowden, EA; Goltzman, D; Ioannidis, G; Josse, RG; Ste-Marie, LG; Tenenhouse, AM; Davison, KS; Blocka, KLN; Pollock, AP; Sibley, J
      Management of corticosteroid-induced osteoporosis

      SEMINARS IN ARTHRITIS AND RHEUMATISM
    86. Geltser, BI; Kochetkova, EA; Nevzorova, VA; Konovalova, EN; Rubashek, IA
      Chronic obstructive pulmonary diseases and osteoporosis

      TERAPEVTICHESKII ARKHIV
    87. Scott, EM; Gaywood, I; Scott, BB
      Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease

      GUT
    88. Coutlakis, P; Buckley, LM
      Glucocorticoid-induced osteoporosis: Prevention and treatment

      BULLETIN ON THE RHEUMATIC DISEASES
    89. Ringe, JD
      Past and future of anabolic agents

      ANNALES DE MEDECINE INTERNE
    90. Greenspan, SL; Harris, ST; Bone, H; Miller, PD; Orwoll, ES; Watts, NB; Rosen, CJ
      Bisphosphonates: Safety and efficacy in the treatment and prevention of osteoporosis

      AMERICAN FAMILY PHYSICIAN
    91. Tobias, JH
      Management of steroid-induced osteoporosis: what is the current state of play?

      RHEUMATOLOGY
    92. Cortet, B; Hachulla, E; Barton, I; Bonvoisin, B; Roux, C
      Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases - A randomized study

      REVUE DU RHUMATISME
    93. Kuntz, D
      Fluoride therapy in osteoporosis: the tide is ebbing

      REVUE DU RHUMATISME
    94. Ljunghall, S; Ljunggren, O
      Inflammatory bowel disease and osteoporosis

      ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    95. Tangsinmankong, N; Bahna, SL; Good, RA
      Osteoporosis for the allergist

      ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
    96. Adachi, JD; Rostom, A
      Metabolic bone disease in adults with inflammatory bowel disease

      INFLAMMATORY BOWEL DISEASES
    97. Buchman, AL
      Bones and Crohn's: Problems and solutions

      INFLAMMATORY BOWEL DISEASES
    98. Schnitzer, TJ
      Pathophysiology of glucocorticoid-induced osteoporosis

      JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
    99. Lane, NF; Lukert, B
      Prevention and treatment of glucocorticoid-induced osteoporosis

      JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
    100. Zaqqa, D; Jackson, RD
      Diagnosis and treatment of glucocorticoid induced osteoporosis

      CLEVELAND CLINIC JOURNAL OF MEDICINE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/08/20 alle ore 17:13:33